Epoprostenol Market, Global Outlook and Forecast 2023-2028

Report ID: 1140112 | Published Date: Jan 2025 | No. of Page: 77 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Epoprostenol Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Sale Channel
    1.3 Global Epoprostenol Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Epoprostenol Overall Market Size
    2.1 Global Epoprostenol Market Size: 2021 VS 2028
    2.2 Global Epoprostenol Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Epoprostenol Sales: 2017-2028
3 Company Landscape
    3.1 Top Epoprostenol Players in Global Market
    3.2 Top Global Epoprostenol Companies Ranked by Revenue
    3.3 Global Epoprostenol Revenue by Companies
    3.4 Global Epoprostenol Sales by Companies
    3.5 Global Epoprostenol Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Epoprostenol Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Epoprostenol Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Epoprostenol Players in Global Market
        3.8.1 List of Global Tier 1 Epoprostenol Companies
        3.8.2 List of Global Tier 2 and Tier 3 Epoprostenol Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Epoprostenol Market Size Markets, 2021 & 2028
        4.1.2 Oral Epoprostenol
        4.1.3 Injection Epoprostenol
    4.2 By Type - Global Epoprostenol Revenue & Forecasts
        4.2.1 By Type - Global Epoprostenol Revenue, 2017-2022
        4.2.2 By Type - Global Epoprostenol Revenue, 2023-2028
        4.2.3 By Type - Global Epoprostenol Revenue Market Share, 2017-2028
    4.3 By Type - Global Epoprostenol Sales & Forecasts
        4.3.1 By Type - Global Epoprostenol Sales, 2017-2022
        4.3.2 By Type - Global Epoprostenol Sales, 2023-2028
        4.3.3 By Type - Global Epoprostenol Sales Market Share, 2017-2028
    4.4 By Type - Global Epoprostenol Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Sale Channel
    5.1 Overview
        5.1.1 By Sale Channel - Global Epoprostenol Market Size, 2021 & 2028
        5.1.2 Hospital Pharmacy
        5.1.3 Retail Pharmacy
        5.1.4 Online Pharmacy
    5.2 By Sale Channel - Global Epoprostenol Revenue & Forecasts
        5.2.1 By Sale Channel - Global Epoprostenol Revenue, 2017-2022
        5.2.2 By Sale Channel - Global Epoprostenol Revenue, 2023-2028
        5.2.3 By Sale Channel - Global Epoprostenol Revenue Market Share, 2017-2028
    5.3 By Sale Channel - Global Epoprostenol Sales & Forecasts
        5.3.1 By Sale Channel - Global Epoprostenol Sales, 2017-2022
        5.3.2 By Sale Channel - Global Epoprostenol Sales, 2023-2028
        5.3.3 By Sale Channel - Global Epoprostenol Sales Market Share, 2017-2028
    5.4 By Sale Channel - Global Epoprostenol Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Epoprostenol Market Size, 2021 & 2028
    6.2 By Region - Global Epoprostenol Revenue & Forecasts
        6.2.1 By Region - Global Epoprostenol Revenue, 2017-2022
        6.2.2 By Region - Global Epoprostenol Revenue, 2023-2028
        6.2.3 By Region - Global Epoprostenol Revenue Market Share, 2017-2028
    6.3 By Region - Global Epoprostenol Sales & Forecasts
        6.3.1 By Region - Global Epoprostenol Sales, 2017-2022
        6.3.2 By Region - Global Epoprostenol Sales, 2023-2028
        6.3.3 By Region - Global Epoprostenol Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Epoprostenol Revenue, 2017-2028
        6.4.2 By Country - North America Epoprostenol Sales, 2017-2028
        6.4.3 US Epoprostenol Market Size, 2017-2028
        6.4.4 Canada Epoprostenol Market Size, 2017-2028
        6.4.5 Mexico Epoprostenol Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Epoprostenol Revenue, 2017-2028
        6.5.2 By Country - Europe Epoprostenol Sales, 2017-2028
        6.5.3 Germany Epoprostenol Market Size, 2017-2028
        6.5.4 France Epoprostenol Market Size, 2017-2028
        6.5.5 U.K. Epoprostenol Market Size, 2017-2028
        6.5.6 Italy Epoprostenol Market Size, 2017-2028
        6.5.7 Russia Epoprostenol Market Size, 2017-2028
        6.5.8 Nordic Countries Epoprostenol Market Size, 2017-2028
        6.5.9 Benelux Epoprostenol Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Epoprostenol Revenue, 2017-2028
        6.6.2 By Region - Asia Epoprostenol Sales, 2017-2028
        6.6.3 China Epoprostenol Market Size, 2017-2028
        6.6.4 Japan Epoprostenol Market Size, 2017-2028
        6.6.5 South Korea Epoprostenol Market Size, 2017-2028
        6.6.6 Southeast Asia Epoprostenol Market Size, 2017-2028
        6.6.7 India Epoprostenol Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Epoprostenol Revenue, 2017-2028
        6.7.2 By Country - South America Epoprostenol Sales, 2017-2028
        6.7.3 Brazil Epoprostenol Market Size, 2017-2028
        6.7.4 Argentina Epoprostenol Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Epoprostenol Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Epoprostenol Sales, 2017-2028
        6.8.3 Turkey Epoprostenol Market Size, 2017-2028
        6.8.4 Israel Epoprostenol Market Size, 2017-2028
        6.8.5 Saudi Arabia Epoprostenol Market Size, 2017-2028
        6.8.6 UAE Epoprostenol Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Actelion
        7.1.1 Actelion Corporate Summary
        7.1.2 Actelion Business Overview
        7.1.3 Actelion Epoprostenol Major Product Offerings
        7.1.4 Actelion Epoprostenol Sales and Revenue in Global (2017-2022)
        7.1.5 Actelion Key News
    7.2 Glaxosmithkline Inc
        7.2.1 Glaxosmithkline Inc Corporate Summary
        7.2.2 Glaxosmithkline Inc Business Overview
        7.2.3 Glaxosmithkline Inc Epoprostenol Major Product Offerings
        7.2.4 Glaxosmithkline Inc Epoprostenol Sales and Revenue in Global (2017-2022)
        7.2.5 Glaxosmithkline Inc Key News
    7.3 Sandoz Canada Incorporated
        7.3.1 Sandoz Canada Incorporated Corporate Summary
        7.3.2 Sandoz Canada Incorporated Business Overview
        7.3.3 Sandoz Canada Incorporated Epoprostenol Major Product Offerings
        7.3.4 Sandoz Canada Incorporated Epoprostenol Sales and Revenue in Global (2017-2022)
        7.3.5 Sandoz Canada Incorporated Key News
    7.4 Teva Parenteral
        7.4.1 Teva Parenteral Corporate Summary
        7.4.2 Teva Parenteral Business Overview
        7.4.3 Teva Parenteral Epoprostenol Major Product Offerings
        7.4.4 Teva Parenteral Epoprostenol Sales and Revenue in Global (2017-2022)
        7.4.5 Teva Parenteral Key News
    7.5 Bayer AG
        7.5.1 Bayer AG Corporate Summary
        7.5.2 Bayer AG Business Overview
        7.5.3 Bayer AG Epoprostenol Major Product Offerings
        7.5.4 Bayer AG Epoprostenol Sales and Revenue in Global (2017-2022)
        7.5.5 Bayer AG Key News
    7.6 SteadyMed
        7.6.1 SteadyMed Corporate Summary
        7.6.2 SteadyMed Business Overview
        7.6.3 SteadyMed Epoprostenol Major Product Offerings
        7.6.4 SteadyMed Epoprostenol Sales and Revenue in Global (2017-2022)
        7.6.5 SteadyMed Key News
    7.7 Reata Pharmaceuticals
        7.7.1 Reata Pharmaceuticals Corporate Summary
        7.7.2 Reata Pharmaceuticals Business Overview
        7.7.3 Reata Pharmaceuticals Epoprostenol Major Product Offerings
        7.7.4 Reata Pharmaceuticals Epoprostenol Sales and Revenue in Global (2017-2022)
        7.7.5 Reata Pharmaceuticals Key News
    7.8 Arena Pharmaceuticals
        7.8.1 Arena Pharmaceuticals Corporate Summary
        7.8.2 Arena Pharmaceuticals Business Overview
        7.8.3 Arena Pharmaceuticals Epoprostenol Major Product Offerings
        7.8.4 Arena Pharmaceuticals Epoprostenol Sales and Revenue in Global (2017-2022)
        7.8.5 Arena Pharmaceuticals Key News
    7.9 Merck
        7.9.1 Merck Corporate Summary
        7.9.2 Merck Business Overview
        7.9.3 Merck Epoprostenol Major Product Offerings
        7.9.4 Merck Epoprostenol Sales and Revenue in Global (2017-2022)
        7.9.5 Merck Key News
8 Global Epoprostenol Production Capacity, Analysis
    8.1 Global Epoprostenol Production Capacity, 2017-2028
    8.2 Epoprostenol Production Capacity of Key Manufacturers in Global Market
    8.3 Global Epoprostenol Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Epoprostenol Supply Chain Analysis
    10.1 Epoprostenol Industry Value Chain
    10.2 Epoprostenol Upstream Market
    10.3 Epoprostenol Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Epoprostenol Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

List of Tables
    Table 1. Key Players of Epoprostenol in Global Market
    Table 2. Top Epoprostenol Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Epoprostenol Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Epoprostenol Revenue Share by Companies, 2017-2022
    Table 5. Global Epoprostenol Sales by Companies, (MT), 2017-2022
    Table 6. Global Epoprostenol Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Epoprostenol Price (2017-2022) & (USD/MT)
    Table 8. Global Manufacturers Epoprostenol Product Type
    Table 9. List of Global Tier 1 Epoprostenol Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Epoprostenol Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Epoprostenol Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Epoprostenol Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Epoprostenol Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Epoprostenol Sales (MT), 2017-2022
    Table 15. By Type - Global Epoprostenol Sales (MT), 2023-2028
    Table 16. By Sale Channel – Global Epoprostenol Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Sale Channel - Global Epoprostenol Revenue (US$, Mn), 2017-2022
    Table 18. By Sale Channel - Global Epoprostenol Revenue (US$, Mn), 2023-2028
    Table 19. By Sale Channel - Global Epoprostenol Sales (MT), 2017-2022
    Table 20. By Sale Channel - Global Epoprostenol Sales (MT), 2023-2028
    Table 21. By Region – Global Epoprostenol Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Epoprostenol Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Epoprostenol Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Epoprostenol Sales (MT), 2017-2022
    Table 25. By Region - Global Epoprostenol Sales (MT), 2023-2028
    Table 26. By Country - North America Epoprostenol Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Epoprostenol Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Epoprostenol Sales, (MT), 2017-2022
    Table 29. By Country - North America Epoprostenol Sales, (MT), 2023-2028
    Table 30. By Country - Europe Epoprostenol Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Epoprostenol Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Epoprostenol Sales, (MT), 2017-2022
    Table 33. By Country - Europe Epoprostenol Sales, (MT), 2023-2028
    Table 34. By Region - Asia Epoprostenol Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Epoprostenol Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Epoprostenol Sales, (MT), 2017-2022
    Table 37. By Region - Asia Epoprostenol Sales, (MT), 2023-2028
    Table 38. By Country - South America Epoprostenol Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Epoprostenol Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Epoprostenol Sales, (MT), 2017-2022
    Table 41. By Country - South America Epoprostenol Sales, (MT), 2023-2028
    Table 42. By Country - Middle East & Africa Epoprostenol Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Epoprostenol Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Epoprostenol Sales, (MT), 2017-2022
    Table 45. By Country - Middle East & Africa Epoprostenol Sales, (MT), 2023-2028
    Table 46. Actelion Corporate Summary
    Table 47. Actelion Epoprostenol Product Offerings
    Table 48. Actelion Epoprostenol Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
    Table 49. Glaxosmithkline Inc Corporate Summary
    Table 50. Glaxosmithkline Inc Epoprostenol Product Offerings
    Table 51. Glaxosmithkline Inc Epoprostenol Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
    Table 52. Sandoz Canada Incorporated Corporate Summary
    Table 53. Sandoz Canada Incorporated Epoprostenol Product Offerings
    Table 54. Sandoz Canada Incorporated Epoprostenol Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
    Table 55. Teva Parenteral Corporate Summary
    Table 56. Teva Parenteral Epoprostenol Product Offerings
    Table 57. Teva Parenteral Epoprostenol Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
    Table 58. Bayer AG Corporate Summary
    Table 59. Bayer AG Epoprostenol Product Offerings
    Table 60. Bayer AG Epoprostenol Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
    Table 61. SteadyMed Corporate Summary
    Table 62. SteadyMed Epoprostenol Product Offerings
    Table 63. SteadyMed Epoprostenol Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
    Table 64. Reata Pharmaceuticals Corporate Summary
    Table 65. Reata Pharmaceuticals Epoprostenol Product Offerings
    Table 66. Reata Pharmaceuticals Epoprostenol Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
    Table 67. Arena Pharmaceuticals Corporate Summary
    Table 68. Arena Pharmaceuticals Epoprostenol Product Offerings
    Table 69. Arena Pharmaceuticals Epoprostenol Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
    Table 70. Merck Corporate Summary
    Table 71. Merck Epoprostenol Product Offerings
    Table 72. Merck Epoprostenol Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
    Table 73. Epoprostenol Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
    Table 74. Global Epoprostenol Capacity Market Share of Key Manufacturers, 2020-2022
    Table 75. Global Epoprostenol Production by Region, 2017-2022 (MT)
    Table 76. Global Epoprostenol Production by Region, 2023-2028 (MT)
    Table 77. Epoprostenol Market Opportunities & Trends in Global Market
    Table 78. Epoprostenol Market Drivers in Global Market
    Table 79. Epoprostenol Market Restraints in Global Market
    Table 80. Epoprostenol Raw Materials
    Table 81. Epoprostenol Raw Materials Suppliers in Global Market
    Table 82. Typical Epoprostenol Downstream
    Table 83. Epoprostenol Downstream Clients in Global Market
    Table 84. Epoprostenol Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Epoprostenol Segment by Type
    Figure 2. Epoprostenol Segment by Sale Channel
    Figure 3. Global Epoprostenol Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Epoprostenol Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Epoprostenol Revenue, 2017-2028 (US$, Mn)
    Figure 7. Epoprostenol Sales in Global Market: 2017-2028 (MT)
    Figure 8. The Top 3 and 5 Players Market Share by Epoprostenol Revenue in 2021
    Figure 9. By Type - Global Epoprostenol Sales Market Share, 2017-2028
    Figure 10. By Type - Global Epoprostenol Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Epoprostenol Price (USD/MT), 2017-2028
    Figure 12. By Sale Channel - Global Epoprostenol Sales Market Share, 2017-2028
    Figure 13. By Sale Channel - Global Epoprostenol Revenue Market Share, 2017-2028
    Figure 14. By Sale Channel - Global Epoprostenol Price (USD/MT), 2017-2028
    Figure 15. By Region - Global Epoprostenol Sales Market Share, 2017-2028
    Figure 16. By Region - Global Epoprostenol Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Epoprostenol Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Epoprostenol Sales Market Share, 2017-2028
    Figure 19. US Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Epoprostenol Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Epoprostenol Sales Market Share, 2017-2028
    Figure 24. Germany Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 25. France Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Epoprostenol Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Epoprostenol Sales Market Share, 2017-2028
    Figure 33. China Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 37. India Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Epoprostenol Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Epoprostenol Sales Market Share, 2017-2028
    Figure 40. Brazil Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Epoprostenol Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Epoprostenol Sales Market Share, 2017-2028
    Figure 44. Turkey Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Epoprostenol Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Epoprostenol Production Capacity (MT), 2017-2028
    Figure 49. The Percentage of Production Epoprostenol by Region, 2021 VS 2028
    Figure 50. Epoprostenol Industry Value Chain
    Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
77
Frequently Asked Questions
Epoprostenol Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Epoprostenol Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Epoprostenol Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports